S&P 500   3,359.31 (+0.71%)
DOW   27,733.80 (+1.02%)
QQQ   278.79 (+1.03%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
S&P 500   3,359.31 (+0.71%)
DOW   27,733.80 (+1.02%)
QQQ   278.79 (+1.03%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
S&P 500   3,359.31 (+0.71%)
DOW   27,733.80 (+1.02%)
QQQ   278.79 (+1.03%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
S&P 500   3,359.31 (+0.71%)
DOW   27,733.80 (+1.02%)
QQQ   278.79 (+1.03%)
AAPL   116.44 (+2.06%)
MSFT   210.82 (+1.72%)
FB   263.24 (+0.55%)
GOOGL   1,477.48 (+0.78%)
AMZN   3,164.31 (+0.62%)
TSLA   429.68 (+2.53%)
NVDA   543.13 (+2.67%)
BABA   292.82 (+5.74%)
CGC   14.40 (-0.69%)
MU   47.42 (-6.49%)
GE   6.22 (+1.63%)
AMD   82.54 (+0.94%)
T   28.42 (+0.42%)
F   6.64 (+0.61%)
ACB   4.68 (+0.00%)
GILD   63.01 (+1.47%)
NFLX   500.75 (+1.47%)
DIS   124.35 (-0.84%)
BA   166.27 (+1.63%)
BAC   24.08 (+1.30%)
Log in
NYSE:BAK

Braskem Stock Forecast, Price & News

$7.41
+0.31 (+4.37 %)
(As of 09/30/2020 02:58 PM ET)
Add
Compare
Today's Range
$7.25
Now: $7.41
$7.41
50-Day Range
$7.04
MA: $8.30
$9.40
52-Week Range
$3.86
Now: $7.41
$18.64
Volume1,378 shs
Average Volume134,030 shs
Market Capitalization$2.95 billion
P/E RatioN/A
Dividend Yield5.40%
Beta1.55
Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through five segments: Chemicals, Polyolefins, United States and Europe, Mexico, Vinyls. The Chemicals segment produces and sells ethylene, propylene butadiene, toluene, xylene, cumene, and benzene, as well as gasoline, diesel and liquefied petroleum gas, and other petroleum derivatives; and supplies electric energy, steam, compressed air, and other inputs to second-generation producers. The Polyolefins segment produces and sells polyethylene and polypropylene. The United States and Europe segment produces and sells polypropylene in the United States and Europe. The Mexico segment produces and sells ethylene, high-density polyethylene, and low-density polyethylene in Mexico. The Vinyls segment produces and sells polyvinyl chloride and caustic soda. The company also manufactures, trades in, imports, and exports chemicals, petrochemicals, and fuels; produces, supplies, and sells utilities, such as steam, water, compressed air, and industrial gases; and provides industrial services. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is based in São Paulo, Brazil.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.43 out of 5 stars


Industry, Sector and Symbol

Industry Industrial organic chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone55-11-3576-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$12.72 billion
Cash Flow$0.60 per share
Book Value$2.51 per share

Profitability

Net Income$-643,890,000.00

Miscellaneous

Employees7,940
Market Cap$2.95 billion
Next Earnings Date11/12/2020 (Estimated)
OptionableOptionable
$7.41
+0.31 (+4.37 %)
(As of 09/30/2020 02:58 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BAK News and Ratings via Email

Sign-up to receive the latest news and ratings for BAK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Braskem (NYSE:BAK) Frequently Asked Questions

How has Braskem's stock been impacted by COVID-19?

Braskem's stock was trading at $9.21 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BAK stock has decreased by 19.5% and is now trading at $7.41.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Braskem?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Braskem in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Braskem
.

When is Braskem's next earnings date?

Braskem is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Braskem
.

How were Braskem's earnings last quarter?

Braskem S.A. (NYSE:BAK) issued its earnings results on Thursday, August, 6th. The company reported ($1.16) earnings per share for the quarter, hitting analysts' consensus estimates of ($1.16). The company earned $2.09 billion during the quarter. Braskem had a negative return on equity of 962.43% and a negative net margin of 19.50%.
View Braskem's earnings history
.

What price target have analysts set for BAK?

3 Wall Street analysts have issued 12-month target prices for Braskem's stock. Their forecasts range from $13.50 to $13.50. On average, they anticipate Braskem's share price to reach $13.50 in the next twelve months. This suggests a possible upside of 82.2% from the stock's current price.
View analysts' price targets for Braskem
.

Who are some of Braskem's key competitors?

What other stocks do shareholders of Braskem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Braskem investors own include Amarin (AMRN), Micron Technology (MU), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Aduro BioTech (ADRO), Armata Pharmaceuticals (ARMP), Crispr Therapeutics (CRSP), Chevron (CVX) and Enterprise Products Partners (EPD).

Who are Braskem's key executives?

Braskem's management team includes the following people:
  • Mr. Roberto Lopes Pontes Simões, Chief Exec. Officer (Age 63)
  • Mr. Pedro van Langendonck Teixeira de Freitas, CFO and Investor Relations & External Affairs Officer (Age 45)
  • Mr. Luiz Eduardo Valente Moreira, Exec. Officer and Head of Investments & Portfolio (Age 63)
  • Mr. Everson Bassinello, Chief Compliance Officer
  • Ms. Cristiana Lapa, Gen. Counsel & Corp. Governance Officer (Age 43)

What is Braskem's stock symbol?

Braskem trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAK."

How do I buy shares of Braskem?

Shares of BAK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Braskem's stock price today?

One share of BAK stock can currently be purchased for approximately $7.41.

How big of a company is Braskem?

Braskem has a market capitalization of $2.95 billion and generates $12.72 billion in revenue each year. The company earns $-643,890,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Braskem employs 7,940 workers across the globe.

What is Braskem's official website?

The official website for Braskem is www.braskem.com.br.

How can I contact Braskem?

Braskem's mailing address is Rua Lemos Monteiro 120 24 andar, Butanta D5, 05501-050. The company can be reached via phone at 55-11-3576-9000 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.